Health Advance, Inc.
CIK:0001531477|SEC Filings
CONDENSED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 12 Months Ended |
|---|---|---|
Sep. 30, 2017 |
Jul. 31, 2016 |
|
| Details | ||
| SALES | $ 0 | $ 0 |
| COST OF SALES | 0 | 0 |
| GROSS PROFIT | 0 | 0 |
| EXPENSES | ||
| Media Services | 1,548 | |
| Legal Services | 20,525 | |
| Amortization | 15,000 | 0 |
| Professional fees | 3,200 | 25,136 |
| Independent Contractors | 25,470 | 0 |
| Office and general | 8,545 | 4,367 |
| Total expenses | 74,288 | 29,503 |
| Foreign exchange loss | 0 | 0 |
| Loss before income taxes | (74,288) | (29,503) |
| Income taxes | 0 | 0 |
| NET AND COMPREHENSIVE LOSS FOR THE PERIOD | $ (74,288) | $ (29,503) |
| Loss per common share, basic and diluted | $ (0.0006) | $ (0.0012) |
| Weighted average number of common stock outstanding, basic and diluted | 126,297,500 | 24,520,000 |
Statements of Cash Flows - USD ($) |
3 Months Ended | 12 Months Ended |
|---|---|---|
Sep. 30, 2017 |
Jul. 31, 2016 |
|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net loss for the period | $ (74,288) | $ (29,503) |
| Adjustments for non-cash items | ||
| Common stock issued for services | 0 | 0 |
| Amortization | 15,000 | 0 |
| Advances from a stockholder | 0 | 0 |
| Net change in non-cash working capital balances: | ||
| Accounts payable and Accrued liabilities | 53,788 | 3,735 |
| Net cash used in operating activities | (5,500) | (25,768) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Proceeds from issuance of common stock | 0 | 0 |
| Advances from a shareholder | 5,600 | 25,768 |
| Net cash provided by financing activities | 5,600 | 25,768 |
| Net increase in cash during the period | 100 | 0 |
| Cash, beginning of period | 0 | 0 |
| Cash, end of period | $ 100 | $ 0 |
CONDENSED BALANCE SHEETS - USD ($) |
Sep. 30, 2017 |
Jul. 31, 2016 |
|---|---|---|
| ASSET | ||
| License agreement costs, net of accumulated amortization of $35,000 (Note 9) | $ 2,965,000 | $ 0 |
| CURRENT ASSET | ||
| Cash | 100 | 0 |
| TOTAL ASSET | 2,965,100 | 0 |
| CURRENT LIABILITIES | ||
| Accounts payable | 17,891 | 58,353 |
| Accrued liabilities | 159,896 | 2,500 |
| Advances from a shareholder (Note 6) | 6,409 | 98,542 |
| Short Term Loans | 98,922 | |
| TOTAL LIABILITIES | 283,118 | 159,395 |
| SHAREHOLDERS' DEFICIENCY | ||
| Authorized:500,000,000 common stock, par value $0.001 Issued and outstanding: 126,797,500 common stock as at September 30, 2017 and 24,520,000 common stock as at January 31, 2017 | 126,797 | 24,520 |
| Additional paid-in capital | 3,083,803 | 186,080 |
| Common stock to be issued | 67,500 | 67,500 |
| Accumulated deficit | (596,118) | (437,495) |
| TOTAL SHAREHOLDERS' DEFICIENCY | 2,681,982 | (159,395) |
| TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIENCY | $ 2,965,100 | $ 0 |